Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1957 2
1958 1
1960 1
1961 1
1963 1
1964 2
1966 3
1967 2
1968 4
1969 3
1970 4
1971 6
1972 9
1973 3
1974 1
1975 7
1976 13
1977 5
1978 8
1979 9
1980 16
1981 16
1982 17
1983 23
1984 17
1985 14
1986 12
1987 23
1988 23
1989 23
1990 28
1991 21
1992 17
1993 15
1994 24
1995 18
1996 18
1997 23
1998 18
1999 17
2000 17
2001 22
2002 18
2003 21
2004 17
2005 13
2006 14
2007 8
2008 18
2009 10
2010 10
2011 9
2012 15
2013 9
2014 7
2015 6
2016 5
2017 2
2018 6
2019 3
2020 10
2021 7
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

698 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Progestogen ester"
Page 1
Cholesterol ester droplets and steroidogenesis.
Kraemer FB, Khor VK, Shen WJ, Azhar S. Kraemer FB, et al. Mol Cell Endocrinol. 2013 May 22;371(1-2):15-9. doi: 10.1016/j.mce.2012.10.012. Epub 2012 Oct 23. Mol Cell Endocrinol. 2013. PMID: 23089211 Free PMC article. Review.
Intracellular lipid droplets (LDs) are dynamic organelles that contain a number of associated proteins including perilipin (Plin) and vimentin. Cholesteryl ester (CE)-rich LDs normally accumulate in steroidogenic cells and their mobilization is the preferred initial source …
Intracellular lipid droplets (LDs) are dynamic organelles that contain a number of associated proteins including perilipin (Plin) and viment …
Presence and detection of endogenous steroids in the horse-A review.
Viljanto M, Gray B, Scarth J. Viljanto M, et al. Drug Test Anal. 2023 Dec 13. doi: 10.1002/dta.3624. Online ahead of print. Drug Test Anal. 2023. PMID: 38092431 Review.
The current internationally adopted approaches include concentration-based thresholds in urine and plasma, steroid ratios in urine and targeting the administered intact steroid esters in plasma and hair. However, these have their limitations, and therefore, other strategie …
The current internationally adopted approaches include concentration-based thresholds in urine and plasma, steroid ratios in urine and targe …
Long-acting hormonal contraceptives for women.
Garza-Flores J, Hall PE, Perez-Palacios G. Garza-Flores J, et al. J Steroid Biochem Mol Biol. 1991;40(4-6):697-704. doi: 10.1016/0960-0760(91)90293-e. J Steroid Biochem Mol Biol. 1991. PMID: 1958567 Review.
A survey of recent trials of new injectable hormonal contraceptives, progestogen-only, levonorgestrel esters, and once monthly injectables, follows a brief review of all the experimental long-acting contraceptive modalities, injectables, implants, vaginal rings, and …
A survey of recent trials of new injectable hormonal contraceptives, progestogen-only, levonorgestrel esters, and once monthly …
Once-a-month estrogen/progestogen injectables.
D'arcangues C. D'arcangues C. Entre Nous Cph Den. 1991 Dec;(19):15. Entre Nous Cph Den. 1991. PMID: 12222332
Researchers find that adding estrogen to DMPA and NET-EN treats these irregularities. They must use esters with limited action to protect the endometrium from constant estrogens, however, which requires monthly injections. ...
Researchers find that adding estrogen to DMPA and NET-EN treats these irregularities. They must use esters with limited action to pro …
Sex hormones and lipoprotein(a) concentration.
Gaeta G, Lanero S, Barra S, Silvestri N, Cuomo V, Materazzi C, Vitagliano G. Gaeta G, et al. Expert Opin Investig Drugs. 2011 Feb;20(2):221-38. doi: 10.1517/13543784.2011.548804. Epub 2011 Jan 4. Expert Opin Investig Drugs. 2011. PMID: 21204723 Review.
The effect of sex hormones on Lp(a) level is related to the setting, the drug, the dose and the way of administration. Androgen esters, oral estrogens, alone or in combination with progestogens, and tibolone constantly decrease Lp(a) level, especially in postmenopau …
The effect of sex hormones on Lp(a) level is related to the setting, the drug, the dose and the way of administration. Androgen esters …
Injectable contraceptives.
Toppozada M. Toppozada M. Contracept Deliv Syst. 1982 Apr;3(2):161-70. Contracept Deliv Syst. 1982. PMID: 12338171
Injectables administered every 2-6 months are composed of a progestogen only. Most of the monthly formulations had to be an estrogen-progestogen combination to provide a reasonable cycle control. The progestogens used in injectables are either derivatives of …
Injectables administered every 2-6 months are composed of a progestogen only. Most of the monthly formulations had to be an estrogen- …
Recent advances in structure of progestins and their binding to progesterone receptors.
Cabeza M, Heuze Y, Sánchez A, Garrido M, Bratoeff E. Cabeza M, et al. J Enzyme Inhib Med Chem. 2015 Feb;30(1):152-9. doi: 10.3109/14756366.2014.895719. Epub 2014 Mar 25. J Enzyme Inhib Med Chem. 2015. PMID: 24666307 Review.
The rational design for potent and effective drugs for the treatment of female cancer must consider the structural changes of the androgen and progestogen skeleton which are an indicator of their activity as progestins or antiprogestins. ...The incorporation of an e …
The rational design for potent and effective drugs for the treatment of female cancer must consider the structural changes of the androgen a …
Pharmacokinetics of once-a-month injectable contraceptives.
Garza-Flores J. Garza-Flores J. Contraception. 1994 Apr;49(4):347-59. doi: 10.1016/0010-7824(94)90032-9. Contraception. 1994. PMID: 8013219 Review.
The addition of a short- or medium-acting estrogen ester to the long-acting progestins depot-medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN) to produce "combined" injectable formulations has proved a successful strategy in the development of …
The addition of a short- or medium-acting estrogen ester to the long-acting progestins depot-medroxyprogesterone acetate (DMPA …
Nandrolone: a multi-faceted doping agent.
Hemmersbach P, Grosse J. Hemmersbach P, et al. Handb Exp Pharmacol. 2010;(195):127-54. doi: 10.1007/978-3-540-79088-4_6. Handb Exp Pharmacol. 2010. PMID: 20020363 Review.
Their forms of application range from injectable fatty acid esters to orally administered nandrolone prohormones. The long detection window for nandrolone ester preparations and the appearance of orally available nandrolone precursors have changed the pattern of mis …
Their forms of application range from injectable fatty acid esters to orally administered nandrolone prohormones. The long detection …
Clinical use of oestrogens and progestogens.
Lauritzen C. Lauritzen C. Maturitas. 1990 Sep;12(3):199-214. doi: 10.1016/0378-5122(90)90004-p. Maturitas. 1990. PMID: 2215269 Review.
Prevention of myocardial infarction and of osteoporosis is now the main argument for long-term substitution of oestrogens and progestogens in the post-menopause and leads to a reduction of overall morbidity and mortality in users. ...Progesterone or its derivatives rather …
Prevention of myocardial infarction and of osteoporosis is now the main argument for long-term substitution of oestrogens and progestogen …
698 results